- RWB has received all regulatory approvals and closed its acquisition of PharmaCo, a Michigan-based marijuana company
- This acquisition opens RWB to over 22 properties, including dispensaries and cultivation sites, giving it complete control of all its operations, from cultivating the product to selling it
- It marks a key milestone for the company and its shareholders as it continues to execute key components of its growth strategy
- For the 2022 calendar year, the company looks to extend its branded product lines, update its dispensaries, create supply chain efficiencies, and grow revenue and profitability
Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) is slowly positioning itself to be one of the most prolific multi-state operators in cannabis and hemp-derived product lines in the United States. Its strategy has mainly consisted of acquisitions across states like Illinois and Massachusetts, with plans to expand to California and Florida.
In what marks a significant milestone for RWB, it has announced having received all regulatory approvals and closing its acquisition of PharmaCo, a Michigan-based marijuana company. This acquisition expands RWB’s footprint within the state, having initially only had a single product line in this market- the Platinum Vape(R) brand (https://ibn.fm/fpiFt).
“I am pleased to announce that we have closed on the PharmaCo acquisition and now control all aspects of our Michigan Operations,” noted Brad Rogers, the Chairman and Chief Executive Officer (“CEO”) of RWB.
“This is a major milestone for RWB and its shareholders as we continue to execute key components of our growth strategy and build our house of brands across our core markets, as promised,” he added.
The acquisition was made via RWB Michigan, LLC, a wholly-owned RWB subsidiary, at a consideration of 37 million RWB units. Each unit consisted of one common share and one series 2 convertible preferred share in the capital of RWB. The transaction also involved converting $30 million in previous advanced loans to PharmaCo into preferred shares in the company issued by RWB Michigan immediately before closing, giving the company 100% ownership of PharmaCo.
This successful acquisition gives RWB access to 22 owned properties, including nine dispensaries and three cultivation sites in Glendale, Marquette, and Au Gres. RWB has also expanded its human resources within the State of Michigan by 180 employees and seeks to offer them competitive wages and incentives to share in the rewards of helping the company achieve its goals.
“We welcome the many talented PharmaCo employees to the RWB team to continue their good work,” noted Mr. Rogers.
“We value their contributions and feel it is important to pay competitive wages and provide key leaders and employees with a stake in the company so they can share in the rewards of helping RWB achieve its goals,” he added.
Going forward, RWB looks to execute its initiatives that include extending its branded product lines, updating its dispensaries to heighten the customer experience, creating supply chain efficiencies, and growing revenue and profitability. This is possible given that the company now controls all Michigan operations, from growing the product to selling it.
Michigan is one of the top cannabis markets in the United States, accounting for over $1.79 billion in sales in 2021 alone.
“We are now in the driver’s seat on over 20 assets across Michigan- one of the largest and fastest-growing cannabis markets in the country,” reckoned Mr. Rogers.
For more information, visit the company’s website at www.RedWhiteBloom.com.
NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
